APA (7th ed.) Citation

Cortés-Sempere, M., de Miguel, M. P., Pernía, O., Rodriguez, C., de Castro Carpeño, J., Nistal, M., . . . de Caceres, I. I. (2013). IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer. Oncogene, 32(10), 1274. https://doi.org/10.1038/onc.2012.146

Chicago Style (17th ed.) Citation

Cortés-Sempere, M., et al. "IGFBP-3 Methylation-derived Deficiency Mediates the Resistance to Cisplatin Through the Activation of the IGFIR/Akt Pathway in Non-small Cell Lung Cancer." Oncogene 32, no. 10 (2013): 1274. https://doi.org/10.1038/onc.2012.146.

MLA (9th ed.) Citation

Cortés-Sempere, M., et al. "IGFBP-3 Methylation-derived Deficiency Mediates the Resistance to Cisplatin Through the Activation of the IGFIR/Akt Pathway in Non-small Cell Lung Cancer." Oncogene, vol. 32, no. 10, 2013, p. 1274, https://doi.org/10.1038/onc.2012.146.